ArticleDigital biomarkers
Smartwatch-Based Screening to Identify Candidates for Deep Brain Stimulation in Parkinson's Disease.
Article in Digital biomarkers. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Introduction: Identifying deep brain stimulation (DBS) candidates, particularly those without access to an advanced specialty center, presents ongoing challenges. This study evaluates the feasibility of a smartwatch system for identifying DBS candidates in Parkinson's disease (PD). Methods: We recruited adults diagnosed with PD and motor complications. Participants wore a consumer smartwatch for at least 4 days per month for 8 months. The smartwatch continuously recorded motion data from its internal motion sensors. Previously validated algorithms used motion data to measure tremor, slowness, and dyskinesia. We compared various metrics in participants who were and were not recommended for DBS and developed an artificial intelligence (AI) model to predict DBS candidacy using features extracted from the motion data. Results: Twenty-three participants were included in the data analysis. Sixteen participants were considered DBS candidates; among them, ten initiated DBS during the study, and six did not due to age or personal preference. Seven participants were not DBS candidates. Bad time (presence of tremor, slowness, and/or dyskinesia as measured by the smartwatch) occurred more often in DBS candidates (3.46 ± 2.23 vs. 1.24 ± 1.23 h/day; Conclusions: The results suggest that sensors in commercial smartwatches and AI can help identify DBS candidates and detect improvements resulting from the therapy. This type of remote patient monitoring could expand access to patients who might not otherwise have considered DBS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.